The World Molecular Imaging Society (WMIS) held its sixth annual congress in Savannah, Ga. September 18-21. The World Molecular Imaging Congress (WMIC) 2013 featured advancements in molecular multimodal imaging with a focus on discovery, pre-clinical and translational research, highlighting first-in-human studies that drive innovative diagnostics and targeted therapy critical to the implementation of precision medicine.

Royal Philips and Accenture announced the creation of a proof-of-concept (POC) demonstration that uses a Google Glass head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions and proves the concept of seamless transfer of patient vital signs into Google Glass, potentially providing physicians with hands-free access to critical clinical information.

Lexmark International Inc. announced the acquisition of Pacsgear. Lexmark paid a cash purchase price of approximately $54 million.

As a new medical center, Hôpital Riviera's daily radiotherapy patient volume started out small, but now the hospital averages 40 patients per day. The introduction of Volumetric Modulated Arc Therapy (VMAT) in many more cases has resulted in a substantial reduction in the time slot — from 15-20 minutes down to 10-15 minutes — which has enabled a 50 percent increase in patients treated per day.

To recognize the advances in the field of nuclear and molecular imaging, as well as the professionals who carry out these procedures, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the SNMMI Technologist Section (SNMMI-TS) celebrate Nuclear Medicine and Molecular Imaging Week, Oct. 6-12, 2013. The theme of this year’s Nuclear Medicine and Molecular Imaging Week is “Molecular Imaging: The Future … Delivered.”